← Back to Search

Dietary Supplement

Hydrogen-rich Water for Mucositis

N/A
Recruiting
Led By Kartik Mani, MD
Research Sponsored by Clare Moran
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor
Planning to receive daily fractionated radiotherapy for over 4 weeks' duration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial investigates if drinking hydrogen-rich water can help head and neck cancer patients who have painful mouth sores from radiation therapy by reducing inflammation and pain.

Who is the study for?
This trial is for individuals with head and neck cancer, who are about to undergo daily radiotherapy for more than 4 weeks. Participants must be able to give consent, have a Karnofsky Performance Score of at least 70, swallow normally, and describe their pain.
What is being tested?
The study is testing if drinking hydrogen-rich water can reduce mouth sores caused by radiation therapy in head and neck cancer patients. It compares the effects of regular water (control) with water containing dissolved hydrogen tablets.
What are the potential side effects?
While not explicitly stated, potential side effects may include mild digestive discomfort or an unusual taste from the hydrogen tablets. Generally, hydrogen-rich water is considered safe with minimal risk of side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with head and neck cancer, at any stage.
Select...
I am scheduled for daily radiotherapy for more than 4 weeks.
Select...
I am able to care for myself but may not be able to do active work.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Group II: ControlPlacebo Group1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Oral Mucositis often involve the use of antioxidants, which work by reducing oxidative stress and inflammation—two major factors in the development of this condition. For instance, Hydrogen-Rich Water, which is being studied for its antioxidant properties, helps neutralize free radicals and decrease inflammatory responses. This mechanism is crucial for Oral Mucositis patients as it can protect the mucosal lining of the mouth from damage, thereby alleviating pain, reducing the risk of secondary infections, and improving the overall quality of life during cancer treatments.
Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.

Find a Location

Who is running the clinical trial?

Clare MoranLead Sponsor
Stony Brook UniversityLead Sponsor
223 Previous Clinical Trials
41,496 Total Patients Enrolled
DrinkHRWUNKNOWN
Kartik Mani, MDPrincipal InvestigatorStony Brook University

Media Library

Hydrogen tablets (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05278260 — N/A
Oral Mucositis Research Study Groups: Control, Active
Oral Mucositis Clinical Trial 2023: Hydrogen tablets Highlights & Side Effects. Trial Name: NCT05278260 — N/A
Hydrogen tablets (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05278260 — N/A
~8 spots leftby Jun 2025